Microbial Products Market Thrives Amid Global Demand for Sustainability

The Microbial Products Market stood at approximately USD 249.31 billion in 2023 and is forecasted to reach USD 492.06 billion by 2030, growing at a robust CAGR of 10.2% over the period. Driven by increasing adoption across agriculture, healthcare, food & beverage, and environmental applications, the market is thriving. The shift toward sustainable, microbe-based solutions is fueling unprecedented demand in multiple regions. The competitive landscape is marked by continual innovation and consolidation, with leading players vying for dominance.

Download PDF Brochure: https://www.maximizemarketresearch.com/request-sample/54098/

United States - Growth & Consolidation

U.S. Microbial Products Market Growth
North America leads globally, with ~42% market share in 2023.
Opportunity: Agri & Healthcare Innovations
Rising use of microbial biofertilizers, biopesticides, enzymes, and diagnostics drives growth.
Trends: Probiotics & Pharma Applications
Expansion in probiotics and therapeutic enzymes fuels growth in healthcare and pharma.
Consolidation: Strategic M&A Moves
Mérieux NutriSciences acquired Bureau Veritas' food-testing units in North America and Asia-Pacific in early 2025.
Updation: Tech & R&D Expansion
Companies are investing in synthetic biology and microbial consortia to bring multifunctional products to market.
Asia‐Pacific - Opportunity & Trends

Asia‐Pacific Market Surge
Region shows the highest CAGR, driven by agriculture demand.
Opportunity: Rapid Agricultural Expansion
FAO projects 22% agricultural growth from 2018-2027, boosting biofertilizer & biopesticide demand.
Trends: Probiotic Adoption & Food Tech
≈70% of Japan's population consumes probiotics daily. Rising plant-based protein and fermentation tech are major trends.
Consolidation: Regional Acquisitions
Ajinomoto acquired U.S.-based Forge Biologics in Nov 2023 for USD 620 million.
Updation: Scaling Biotech Capabilities
Expansion in fermentation infrastructure and synthetic biology R&D are underway.
Europe - Trends & Consolidation

Europe Market Overview
Holds ~28% of revenue with steady CAGR of ~5.8%.
Opportunity: Regulatory Sustainability Policies
EU's Green Deal and agri-regulations favor eco-friendly microbial solutions.
Trends: Enzyme & Biopharma Innovations
Growth in enzyme applications in pharmaceuticals and diagnostics.
Consolidation: Targeted Acquisitions
bioMérieux acquired Suzhou Hybiome majority stake in Nov 2018; continued strategic buys in diagnostics.
Updation: Quality & Compliance
Alignment with EU regulations enhances microbial product safety and validation.
Middle East & Africa - Growth & Updation

Regional Growth
Expected CAGR ~7-8% from 2024 to.
Opportunity: Emerging Agri-Tech Markets
Gulf countries investing in biofertilizers and biocontrol for sustainable agriculture.
Trends: Food Safety & Testing
Microbial diagnostic solutions gain traction amid stricter food regulations.
Consolidation: Global Expansion by Key Players
Mérieux NutriSciences expanded into South Africa and Morocco via Bureau Veritas acquisition in early 2025.
Updation: Infrastructure Enhancement
Growing lab capacity for environmental and food-safety testing.
Region-Specific M&A & Key Recent Developments

United States: Mérieux NutriSciences acquired Bureau Veritas' food-testing business in Canada and U.S. in Jan 2025.
Asia‐Pacific: Ajinomoto bought Forge Biologics for USD 620 million (Nov 2023).
Europe: bioMérieux completed a majority acquisition of Suzhou Hybiome in 2018 and ongoing expansion via diagnostic labs.
Middle East & Africa: Mérieux NutriSciences extended its footprint to South Africa, Asia-Pacific, and Morocco (2025)

Ask for Sample to Know US Tariff Impacts on Microbial Products Unit Market: https://www.maximizemarketresearch.com/request-sample/54098/

Microbial Products Market Segmentation:

by Source

Bacterial
Viral
Fungi

by Type

Enzymes
Polysaccharides
Nutrients
Chemotherapeutic Agents
Antibiotics
Vaccines

by Application

Pharmaceutical
Diagnostic
Biotechnology

by End-User

Pharmaceutical and Biotechnological Industries
Hospitals and Clinics
Diagnostic Labs
Research and Academics

During the projected year, the bacterial category is anticipated to lead the market in terms of source. Methicillin-resistant/sensitive research materials, quality control organisms for commercial identification systems, a broad range of extremophile strains from various environmental sources, and genomic DNA from well-characterized microbial strains appropriate for PCR amplification are just a few of the many uses for bacterial cultures in research institutes and industrial applications. Additionally, a number of bacterial species, anaerobic bacteria, and strains of bacteria that have had their genomes sequenced are among the methods and culture techniques used by different businesses for research and development purposes, and these are anticipated to drive the market going forward.

To uncover more details about this research, follow this link@ https://www.maximizemarketresearch.com/request-sample/54098/

Microbial Products Market Key Players:

1. Kyowa Hakko Bio Co.
2. GlaxoSmithKline plc,
3. NovaDigm Therapeutics
4. Sanofi S.A
5. Novartis AG
6. Merck & Co. Inc.
7. Valent BioSciences Corp.
8. Amgen Inc.
9. Pfizer Inc., Ltd
10.Biomérieux SA
11.Ajinomoto Co. Inc.
12.Certis Usa
13.Durect Corp.
14.Earthrise Nutritionals Llc
15.Energy Derived
16.Environmental Biotechnologies Inc.
17.Genomatica
18.Genzyme Corp
19.Taiwan Chlorella Manufacturing Co.
20.Leadiant
21.AB Mauri
22.Genencor
23.Amyris Inc.

For Customization of the report, please refer to this link: https://www.maximizemarketresearch.com/market-report/global-microbial-products-market/54098/

Key questions answered in Microbial Products Unit Market are:

Who held the largest market share in the Microbial Products Unit Market?
What are the factors driving the Microbial Products Unit Market growth?
What are the factors restraining the Microbial Products Unit Market growth?
Which trends are expected to generate additional revenue for the Microbial Products Unit market growth?
What are the recent industry trends that can be implemented to generate additional revenue streams for the Microbial Products Unit Market?

Want to know where the industry is headed? Check out our trending studies:

♦ Blue Biotechnology Market https://www.maximizemarketresearch.com/market-report/blue-biotechnology-market/14327/

♦ Global Nucleic Acid Labeling Market https://www.maximizemarketresearch.com/market-report/global-nucleic-acid-labeling-market/100798/

♦ Bionics Market https://www.maximizemarketresearch.com/market-report/global-bionics-market/44070/

♦ Feed Yeast Market https://www.maximizemarketresearch.com/market-report/feed-yeast-market/122115/

♦ Global Custom Antibody Market https://www.maximizemarketresearch.com/market-report/global-custom-antibody-market/34046/

♦ Digital PCR (dPCR) and Realtime PCR (qPCR) Market https://www.maximizemarketresearch.com/market-report/global-digital-pcr-dpcr-and-real-time-pcr-qpcr-market/32992/

♦ Global Rapid Microbiology Testing Market https://www.maximizemarketresearch.com/market-report/global-rapid-microbiology-testing-market/21018/

♦ Global Geriatric Medicines Market https://www.maximizemarketresearch.com/market-report/global-geriatric-medicines-market/39382/

♦ Global Downstream Processing Market https://www.maximizemarketresearch.com/market-report/global-downstream-processing-market/20673/

♦ Whole Exome Sequencing Market https://www.maximizemarketresearch.com/market-report/whole-exome-sequencing-market/220646/

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.